Boon-Cher Goh
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
Papers in
-
- Cancer therapeutics and mechanisms 6
- RNA modifications and cancer 5
- Cancer-related gene regulation 4
- Oncology 18
- Cancer-related Molecular Pathways 5
- Cancer Treatment and Pharmacology 4
- Co-authors
- Lingzhi Wang (28 shared papers)Soo Chin Lee (20 shared papers)Nicholas Syn (5 shared papers)Edward Kai‐Hua Chow (2 shared papers)Chwee Teck Lim (1 shared paper)Ross A. Soo (11 shared papers)How-Sung Lee (10 shared papers)Xiaoqiang Xiang (5 shared papers)
- Journals
- Clinical Cancer Research (5 papers)Pharmacogenetics and Genomics (4 papers)Cancers (3 papers)PLoS ONE (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- SingaporeUnited StatesChina
In The Last Decade
Boon-Cher Goh
57 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 111
- Cancer Research 679
- Oncology 763
- Pharmacology 215
- Molecular Biology 1.2k
- Pulmonary and Respiratory Medicine 406
Countries citing papers authored by Boon-Cher Goh
This map shows the geographic impact of Boon-Cher Goh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boon-Cher Goh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boon-Cher Goh more than expected).
Fields of papers citing papers by Boon-Cher Goh
This network shows the impact of papers produced by Boon-Cher Goh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boon-Cher Goh. The network helps show where Boon-Cher Goh may publish in the future.
Co-authors
The 25 scholars most cited alongside Boon-Cher Goh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 358 | |
| 2 | 2002 | 233 | |
| 3 | 2018 | 203 | |
| 4 | 2007 | 114 | |
| 5 | 2015 | 112 | |
| 6 | 2020 | 108 | |
| 7 | 2018 | 104 | |
| 8 | 2020 | 86 | |
| 9 | 2021 | 79 | |
| 10 | 2011 | 78 | |
| 11 | 2008 | 74 | |
| 12 | 2009 | 72 | |
| 13 | 2020 | 68 | |
| 14 | 2008 | 64 | |
| 15 | 2009 | 62 | |
| 16 | 2022 | 61 | |
| 17 | 2011 | 60 | |
| 18 | 2009 | 53 | |
| 19 | 2008 | 51 | |
| 20 | 2018 | 43 |
About Boon-Cher Goh
Boon-Cher Goh is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Pharmacology, having authored 58 papers that have together received 2.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Cancer therapeutics and mechanisms (6 papers), Cancer-related Molecular Pathways (5 papers), RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Treatment and Pharmacology (4 papers), Cancer-related gene regulation (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Cancer Research (679 citations), Oncology (763 citations), Pharmacology (215 citations), Molecular Biology (1.2k citations) and Pulmonary and Respiratory Medicine (406 citations). Boon-Cher Goh has collaborated with scholars based in Singapore, United States and China. Frequent co-authors include Lingzhi Wang, Soo Chin Lee, Nicholas Syn, Edward Kai‐Hua Chow, Chwee Teck Lim, Ross A. Soo, How-Sung Lee, Xiaoqiang Xiang, Sing‐Huang Tan and Andrea Li‐Ann Wong. Their work appears in journals such as Clinical Cancer Research, Pharmacogenetics and Genomics, Cancers, PLoS ONE and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.